ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in New York, NY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Brain Cancer
Glioma
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near New York, NY, USA:

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER)

FRONTIER Study is a prospective, interventional, single-arm, multi-center, study to assess the safety and technical feasibility of TheraSphere GBM...

Enrolling
Recurrent Glioblastoma
Glioblastoma Multiforme
Device: TheraSphere GBM

Early Phase 1

Boston Scientific
Boston Scientific

New York, New York, United States and 4 other locations

efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with radiation and chemotherapy, in subjects with newly-diagnosed glioblastoma...

Active, not recruiting
Glioblastoma
Drug: Temozolomide
Biological: INO-5401

Phase 1, Phase 2

Inovio Pharmaceuticals
Inovio Pharmaceuticals

New York, New York, United States and 20 other locations

A Phase 1b/2, Multicenter, Open-Label Study of ACP-196 in Subjects with Recurrent Glioblastoma Multiforme (GBM)...

Active, not recruiting
Glioblastoma Multiforme
Drug: ACP-196

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

New York, New York, United States and 6 other locations

The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM...

Active, not recruiting
Glioblastoma
Glioblastoma Multiforme
Drug: Dendritic cell immunotherapy

Phase 3

Northwest Biotherapeutics
Northwest Biotherapeutics

New York, New York, United States and 85 other locations

This is a single-arm, open-label phase II clinical trial in which approximately 55 patients with newly diagnosed glioblastoma (GBM)...

Active, not recruiting
Newly Diagnosed Glioblastoma
Biological: AV-GBM-1

Phase 2

AIVITA Biomedical

New Brunswick, New Jersey, United States and 7 other locations

(MTA-based vaccine) in combination with standard care treatment of glioblastoma (GBM) and Tumor Treating Fields (TTFields).The stud...

Active, not recruiting
Glioblastoma
Biological: Peptides
Drug: Poly-ICLC

Phase 1

Albert Einstein College of Medicine

Bronx, New York, United States of America

Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....

Enrolling
Glioblastoma
Drug: Temozolomide
Radiation: Radiation

Phase 2, Phase 3

Global Coalition for Adaptive Research

New York, New York, United States and 61 other locations

therapy alone as a treatment for newly diagnosed MGMT unmethylated glioblastoma patients. The patients' own cancer cells collected after sur...

Enrolling
Glioblastoma Multiforme of Brain
Biological: TVI-Brain-1
Procedure: Standard of Care

Phase 2, Phase 3

TVAX Biomedical

Newark, New Jersey, United States and 4 other locations

with ipilimumab and surgery when used in the treatment of recurrent glioblastoma.The names of the study drugs involved in this study are:* N...

Active, not recruiting
Glioblastoma
Glioblastoma Multiforme
Drug: Nivolumab-Placebo
Drug: Nivolumab

Phase 1

Patrick Wen, MD

New York, New York, United States and 3 other locations

The purpose of this study is to find out if performing additional Magnetic Resonance Image (MRI) scans of the subjects' brain during each week of the...

Enrolling
Glioblastoma
Astrocytoma
Other: Adaptive Radiotherapy
Columbia University
Columbia University

New York, New York, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems